Zobrazeno 1 - 7
of 7
pro vyhledávání: '"W L, Akerley"'
Autor:
W. L. Akerley
Publikováno v:
Archives of Internal Medicine. 153:1681-1688
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c020e791ad369e46a607e2882da23fd2
https://doi.org/10.1001/archinte.153.14.1681
https://doi.org/10.1001/archinte.153.14.1681
Autor:
D M, Savarese, S, Halabi, V, Hars, W L, Akerley, M E, Taplin, P A, Godley, A, Hussain, E J, Small, N J, Vogelzang
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(9)
To investigate the combination of docetaxel, estramustine (EM), and low-dose hydrocortisone in men with hormone-refractory prostate cancer (HRPC).Combinations of EM with other antimitotic agents such as docetaxel are synergistic in vitro and show sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::31d3f609d85abe7293340bbd758d0028
https://pubmed.ncbi.nlm.nih.gov/11331330
https://pubmed.ncbi.nlm.nih.gov/11331330
Autor:
W L, Akerley
Publikováno v:
Surgical oncology clinics of North America. 4(4)
Adjuvant therapy with either chemotherapy or hormonal therapy offers statistically significant benefits for most subsets of women with breast cancer that in many cases outweigh the risks of treatment, but the potential benefit will vary from patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::38552745480455eff4ff555015e0a4e8
https://pubmed.ncbi.nlm.nih.gov/8535905
https://pubmed.ncbi.nlm.nih.gov/8535905
Autor:
W L, Akerley
Publikováno v:
Rhode Island medicine. 78(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4786477cfe4913f7b1dcc0a2e93ce76
https://pubmed.ncbi.nlm.nih.gov/7579720
https://pubmed.ncbi.nlm.nih.gov/7579720
Autor:
Wolfram E. Samlowski, John P. Fruehauf, Kevin M. Kong, W. L. Akerley, James G. Jakowatz, Z. Eroglu
Publikováno v:
Journal of Clinical Oncology. 29:8546-8546
8546 Background: Metastatic melanoma patients have a poor prognosis. Currently only immunotherapy has offered a limited survival benefit. More effective and less toxic treatments are needed. Docetaxel (Taxotere) has clinical activity in melanoma and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ba5f31c6b0cd68a2f410c60ff98f29e
https://doi.org/10.1200/jco.2011.29.15_suppl.8546
https://doi.org/10.1200/jco.2011.29.15_suppl.8546
Publikováno v:
Archives of internal medicine. 153(14)
A study was performed to distinguish between genetic vs socioeconomic factors or artifacts inherent in retrospective studies to discover explanations for the apparent shorter survival of blacks than whites with lung and colon cancer.Detailed biologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20a21a61bb87c195d843b5c42354dfaa
https://pubmed.ncbi.nlm.nih.gov/8333805
https://pubmed.ncbi.nlm.nih.gov/8333805
Publikováno v:
Blood. 77(3)
The high-affinity, type I Ig Fc receptor (Fc gamma RI) for human IgG1, human IgG3, murine IgG2a, and murine IgG3 is highly expressed on monocytes, neutrophils (PMN) in certain disease states, and phagocytes treated with interferon-gamma (IFN-gamma).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40c69cee645254b7cde546e50a8dd777
https://pubmed.ncbi.nlm.nih.gov/1703798
https://pubmed.ncbi.nlm.nih.gov/1703798